A pause can be a useful next step.
If an offer is unclear, leave it unresolved for now. Ask for the name, the rule, or the written answer that would settle the question.
U.S. care context: September 2026.
Ask who checked your need for medicine
As of September 2026, federal law prohibits selling or giving out a prescription medicine unless there is a valid prescription.
- Who is the prescriber responsible for this prescription?
- What is the way to reach that prescriber with my questions?
- How will you check my health needs before writing a prescription?
Ask what the claim of approval refers to
A compounded medicine is made to order for a patient.
The Food and Drug Administration (FDA) checks the evidence about a medicine and the uses named for it.
For September 2026, no compounded medicine has FDA approval; saying otherwise is a false claim.
“FDA registered” means a place that makes or packages medicines is listed with FDA. It does not mean FDA has approved that place or its medicine.
The number identifying a medicine product in FDA’s drug listing is called a National Drug Code (NDC). FDA says having this number does not prove approval.
- Is this claim about the finished medicine, an ingredient, or the place that makes or packages it?
- Where is the actual product approval record?
Read the words on the product label
“For research purposes” means for experiments. “Not for human consumption” means people must not take it.
FDA warns in September 2026 against weight medicines offered to people when their labels read “for research purposes” or read “not for human consumption”. The products’ quality has not been established, and they could be harmful.
FDA records list no U.S. approval for BPC-157, ipamorelin, or retatrutide as of September 2026.
FDA says in September 2026 that federal law prohibits preparing retatrutide or cagrilintide by compounding.
- Ask the prescriber what that status means for the exact offer.
- Ask which approved options could address the same goal.
Keep the payment question open
In September 2026, the Federal Trade Commission (FTC) warns that demands for payment exclusively through a transfer, a payment app, or a gift card are likely scams.
FDA lists very deep discounts as a concern, but a low price alone does not establish that an offer is wrong.
- Get the full quote and cancellation terms in writing.
- Check the prescriber and pharmacy records before committing.
- Bring unclear claims into the visit instead of accepting them as answers.
A short reading list
Food and Drug Administration (FDA) · U.S. medicine review agency
FDA’s guide to claims about compounded medicine
FDA says it is false or misleading to claim that a made-to-order medicine is approved or proven to work exactly like an approved product.
Compare the wording you saw with the exact claim being made.
Federal Trade Commission, Consumer Advice
FTC explanation of payment demands and scams
FTC points to demands for particular payment methods as a way to spot a possible scam.
Read the payment terms alongside the identity and medicine checks.